May, 2006
No. 91 (5)

Articles

The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model (212 Online Views)

E Menu, K Asosingh, S Indraccolo, H De Raeve, I Van Riet, E Van Valckenborgh, I Van de Broek, N Fujii, H Tamamura, B Van Camp, K Vanderkerken

https://doi.org/10.3324/%25x

Biography

Letters to the Editor

Comments

Case Reports

Clinical Trial

Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study (313 Online Views)

J de la Rubia, J Blade, JJ Lahuerta, JM Ribera, R Martinez, A Alegre, J Garcia-Larana, P Fernandez, A Sureda, F de Arriba, D Carrera, J Besalduch, R Garcia Boyero, L Palomera Bernal, MT Hernandez, PR Garcia, J Perez-Calvo, A Alcala, LF Casado, J San Miguel

https://doi.org/10.3324/%25x

Clinical Trial, Phase II

Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes (103 Online Views)

PA Broliden, IM Dahl, R Hast, B Johansson, E Juvonen, L Kjeldsen, A Porwit-MacDonald, M Sjoo, JM Tangen, B Uggla, G Oberg, E Hellstrom-Lindberg

https://doi.org/10.3324/%25x

Comparative Studies

Evaluation Studies